Artemether-Lumefantrine Versus Chloroquine for the Treatment of Uncomplicated Plasmodium knowlesi Malaria: An Open-Label Randomized Controlled Trial CAN KNOW

BACKGROUND: Plasmodium knowlesi is reported increasingly across Southeast Asia and is the most common cause of malaria in Malaysia. No randomized trials have assessed the comparative efficacy of artemether-lumefantrine (AL) for knowlesi malaria. METHODS: A randomized controlled trial was conducted i...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Infect Dis
Autori principali: Grigg, Matthew J, William, Timothy, Barber, Bridget E, Rajahram, Giri S, Menon, Jayaram, Schimann, Emma, Wilkes, Christopher S, Patel, Kaajal, Chandna, Arjun, Price, Ric N, Yeo, Tsin W, Anstey, Nicholas M
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Articles and Commentaries
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5790171/
https://ncbi.nlm.nih.gov/pubmed/29020373
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix779
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi